ReviewAmerican journal of preventive medicine2017
Prevalence and Medical Costs of Chronic Diseases Among Adult Medicaid Beneficiaries.
Review in American journal of preventive medicine, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 91 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
91 citing papers in PubMed, 1 synthesis or guideline pooled it, 164 citations in OpenAlex.
- Pooled it
- Performance evaluation of a new prognostic-efficacy-combination design in the context of telemedical interventions.ESC heart failure · 2022Trial
- Implementation of a six-month produce prescription program for a rural Medicaid population increased vegetable consumption and reduced food insecurity in Washington state.Preventive medicine reports · 2026Article
- Association Between Baseline Glucagon-like Peptide-1 Receptor Agonist Use and Newly Documented Depression Diagnosis in Adults with Type 2 Diabetes: A Multi-State Medicaid Cohort Study.Healthcare (Basel, Switzerland) · 2026Article
- Modelling the Associations Between the Physician-Patient Relationship and Patient Outcomes via Self-Determination Theory Variables in Chronic Disease Management.International journal of behavioral medicine · 2026Article
- Diabetes Diagnosis Patterns in Medicaid: How State Policy, Managed Care, and Social Vulnerability Shape Detection in Medicaid.Medical care · 2026Article
- Mediation of chronic pain and disability on opioid use disorder risk by pain management practices among adult Medicaid patients, 2016-2019.American journal of epidemiology · 2026Article
- Cost of hepatic decompensation and liver transplantation events in primary biliary cholangitis: a retrospective observational study.Journal of comparative effectiveness research · 2026Observational
- Practical Considerations for using Social Determinants of Health for Disease Prediction in All of Us.Research square · 2026Article
- Housing Cost Burden and Outcomes Among Medicaid Beneficiaries With Heart Failure.JAMA health forum · 2026Article
- Health effects of black and blond tobacco: a comparative analysis on smoking-related diseases with emphasis on bronchitis and COPD.Frontiers in public health · 2026Article
- Practical considerations for social determinant-based disease prediction in the All of Us research program.Communications health · 2026Article
- Opioid dose, duration, and risk of use disorder in Medicaid patients with musculoskeletal pain.Pain medicine (Malden, Mass.) · 2026Article
- Association of transfer time and delays with outcomes for patients with acute pulmonary embolism requiring interhospital transfer: a retrospective observational study.Annals of medicine · 2025Observational
- Severe housing cost burden and premature cardiovascular mortality.American journal of preventive cardiology · 2025Article
- Risk analysis of tooth extraction in hypertensive patients under ECG monitoring: a single-center retrospective study.BMC oral health · 2025Article
- Moving to greener neighborhoods and healthcare costs in Northern California.Environmental epidemiology (Philadelphia, Pa.) · 2025Article
- Effectiveness of Case Management for High-Frequency Outpatients and Long-Term Inpatients Among South Korean Medical Aid Beneficiaries.Healthcare (Basel, Switzerland) · 2025Article
- Screening, treatment, and referral for substance use disorder in Medicaid health homes: Results of a national pilot study.Journal of substance use and addiction treatment · 2025Article
- Risk of Opioid Use Disorder in Surgical Patients with Medicaid and Associations with Prescription Opioid Dose and Duration.Journal of pain research · 2025Article
31 more citing papers are in PubMed but not listed here.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 2 institutions in 1 country.
Funding
Abstract
introductionThis review summarizes the current literature for the prevalence and medical costs of noncommunicable chronic diseases among adult Medicaid beneficiaries to inform future program design.
methodsThe databases MEDLINE and CINAHL were searched in August 2016 using keywords, including Medicaid, health status, and healthcare cost, to identify original studies that were published during 2000-2016, examined Medicaid as an independent population group, examined prevalence or medical costs of chronic conditions, and included adults within the age group 18-64 years. The review and data extraction was conducted in Fall 2016-Spring 2017. Disease-related costs (costs specifically to treat the disease) and total costs (all-cause medical costs for a patient with the disease) are presented separately.
resultsAmong the 29 studies selected, prevalence estimates for enrollees aged 18-64 years were 8.8%-11.8% for heart disease, 17.2%-27.4% for hypertension, 16.8%-23.2% for hyperlipidemia, 7.5%-12.7% for diabetes, 9.5% for cancer, 7.8%-19.3% for asthma, 5.0%-22.3% for depression, and 55.7%-62.1% for one or more chronic conditions. Estimated annual per patient disease-related costs (2015 U.S. dollars) were $3,219-$4,674 for diabetes, $3,968-$6,491 for chronic obstructive pulmonary disease, and $989-$3,069 for asthma. Estimated hypertension-related costs were $687, but total costs per hypertensive beneficiary ranged much higher. Estimated total annual healthcare costs were $29,271-$51,937 per beneficiary with heart failure and $11,446-$20,585 per beneficiary with schizophrenia. Costs among beneficiaries with cancer were $29,384-$46,194 for the 6 months following diagnosis.
conclusionsThese findings could help inform the evaluation of interventions to prevent and manage noncommunicable chronic diseases and their potential to control costs among the vulnerable Medicaid population.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.